mGluR2 antagonists (Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamemGluR2 antagonists (Roche)
Drug Alias NameRo-64-5229Ro-676221Ro-016128Ro-674853Ro-718216 +[6] 
ClassificationSmall molecules
Mechanisms of ActionMetabotropic glutamate receptor 2 antagonists
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsPsychotic DisordersAlzheimer DiseaseCentral Nervous System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersAlzheimer DiseaseCentral Nervous System Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A